Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yonghao Nan"'
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0297076 (2024)
In recent years, adipose-derived stem cells (ADSCs) and derived exosomes (ADSC-Ex) have been investigated for their therapeutic potential in various diseases due to their satisfactory differentiation and regeneration ability. We aimed to explore the
Externí odkaz:
https://doaj.org/article/ac01a79c3ed740b1a06463db8bbbcd5e
Autor:
Xiaoliang Chen, Fuquan Jiang, Chunshu Jia, Ming Liu, Yonghao Nan, Licheng Qu, Qingkuo Kong, Fangfang Hou, Wenshan Luo, Wanli Na, Xuefei Jin, Jiufeng Tan
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Non-muscle invasive bladder cancer (NMIBC) patients often have fewer treatment options, and suffer the progression of disease due to mechanisms that are not clear, as well as due to its diversity. This study was designed to explore the molecular mech
Externí odkaz:
https://doaj.org/article/efb3a9cf85b8474491defc9b89862dbb
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Publikováno v:
International Journal of Biological Sciences
Cisplatin-based chemotherapy often results in the development of chemo-resistance when used to treat bladder cancer (BC), which is difficult to overcome. Recent data indicate that pyruvate kinase M2 (PKM2), a glycolytic enzyme for Warburg effect, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5874abd7483fc87a7344f3132417400
https://doi.org/10.7150/ijbs.27854
https://doi.org/10.7150/ijbs.27854
Autor:
HAITAO SONG1,2, YONGHAO NAN1, XINSHENG WANG1, GANG ZHANG1, SHI ZONG1, XIANGBO KONG1 kongxiangbo_cju@163.com
Publikováno v:
Molecular Medicine Reports. Oct2017, Vol. 16 Issue 4, p4279-4286. 8p.
Autor:
Licheng Qu, Fuquan Jiang, Wanli Na, Ming Liu, Fangfang Hou, Chunshu Jia, Jiufeng Tan, Wenshan Luo, Yonghao Nan, Xiaoliang Chen, Xuefei Jin, Qingkuo Kong
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Non-muscle invasive bladder cancer (NMIBC) patients often have fewer treatment options, and suffer the progression of disease due to mechanisms that are not clear, as well as due to its diversity. This study was designed to explore the molecular mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aec2f1d92b3de63190d884407f140d0
http://europepmc.org/articles/PMC6604748
http://europepmc.org/articles/PMC6604748